Foltz et al (30) indicated that histone modification was responsible for the epigenetic modulation of Wnt antagonist, showing that DKK1, SFRP1, and WIF1 had decreased expression in human glioblastoma. This evidence concerns the gene SFRP1 and glioblastoma.